BioNexus Gene Lab Corp.

About BioNexus Gene Lab Corp.

BioNexus Gene Lab Corporation (BGLC) specializes in less-invasive blood-based genomic screening to detect predisposed diseases before symptoms appear. Their mission is to enable early detection of disease susceptibility, allowing individuals to take preventive measures for maintaining health.

Products & Services

Blood-based Genomic Screening (BGS):A less-invasive blood test using circulating RNA to assess risk for 8 common cancers, 2 inflammatory diseases, and osteoarthritis. Utilizes FDA-approved reagents and instruments for quality results.

Specialties

Blood-based Genomic Screening RNA Analysis Early Disease Detection Cancer Screening Inflammatory Disease Detection Osteoarthritis Detection

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 5750000 MR: - FA: $5.75 million FAN: 5750000	D: 2023-07-24 FD: 2023-07-24	1 investors
2	RT: Public Offering T: - FT: Public Offering	A: 5000000 MR: - FA: $5 million FAN: 5000000	D: 2023-07-20 FD: 2023-07-20	1 investors

Public Offering Latest

2023-07-24

$5.8M

1 investor (Pro only)

Public Offering 2023-07-20

$5.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Peter Lewis

Associate Vice-President, Research and Innovation

C

Changming Cheng

Post Doctor and Associate Researcher

S

Stephen Ponnampalam

Scientist

L

Liew Choong - Chin

Professor Emeritus

L

Liew

Professor Emeritus

M

Mohr

View 4 more team members with Pro

Unlock Full Team Directory

Recent News